← All investors

Lancaster Group

1 portfolio company · 1 on the map · $429M raised · 1 cities

Portfolio map

1 Lancaster Group portfolio company on the map.

Portfolio companies

OCUGEN OPCO
Malvern
Ocugen is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes.
Biotechnology Research$429MEst. 2013

Portfolio map

1 Lancaster Group portfolio company on the map.

Lancaster Group portfolio | CleraMap